Promethazine Hydrochloride

4 trials 1 recruiting RRespiratory

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

3 Sponsors

13 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 2 Phase IV: 1

Oversight events:

4 temporary halts across 1 trial

View oversight register →

Indications tested

Diffuse large B-cell lymphoma recurrent 2 Epidermolysis bullosa 1 Diffuse large B-cell lymphoma refractory 1

Sponsors using this IMP

Allogene Therapeutics Inc. 2 Novespace 1 Rheacell GmbH & Co. KG 1

All trials

4 total

Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy (EXPA… Ended

2023-503830-27-00 Phase II 3 countries Allogene Therapeutics Inc.
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA2) Ended

2022-501927-25-00 Phase II 2 countries Allogene Therapeutics Inc.
Effects of promethazine and altered gravity on bimanual coordination Ended

2023-504256-10-00 Phase IV 1 country Novespace

Showing 1–4 of 4 trials

← All drugs A–Z